Show simple item record

dc.contributor.authorNguyen, M T H
dc.contributor.authorOtt, J J
dc.contributor.authorCaputo, M
dc.contributor.authorKeller-Stanislawski, B
dc.contributor.authorKlett-Tammen, C J
dc.contributor.authorLinnig, S
dc.contributor.authorMentzer, D
dc.contributor.authorKrause, G
dc.date.accessioned2021-03-19T14:46:17Z
dc.date.available2021-03-19T14:46:17Z
dc.date.issued2020-01-01
dc.identifier.citationPharmazie. 2020 Jan 2;75(1):27-31. doi: 10.1691/ph.2020.9734.en_US
dc.identifier.issn0031-7144
dc.identifier.pmid32033630
dc.identifier.doi10.1691/ph.2020.9734
dc.identifier.urihttp://hdl.handle.net/10033/622779
dc.description.abstractThe passive surveillance system is an important tool in pharmacovigilance of vaccines. However, reporting of adverse events following immunization (AEFI) post-marketing has limitations regarding under-reporting, biased reports and lack of exposure data resulting in imprecise estimates. New mobile application technology may provide an opportunity for an enhanced surveillance. A pre-requisite for the use of new app-based technology is to identify practical challenges and end users' preferences for design of app-features. The objectives were (i) to investigate the recruitment and feasibility of an app-based study in Germany, (ii) to assess individuals' motivation to participate in such a study and (iii) to identify app-features for reporting AEFI. We conducted a cross-sectional study among employees of a financial institution who attended the occupational health office during the seasonal influenza vaccination in November 2017. Participants tested feasibility and assessed an app prototype for AEFI reporting by using a case vignette and a questionnaire. Of the 153 attending employees, 65 (42%) agreed to participate and returned the questionnaire. Twenty-three (63%) rated the experience of reporting AEFI with the app prototype to be positive. Among three features offered for gamification, collecting points was most frequently chosen (n=22, 34%). The main reason for declining participation was the apprehension about data protection (n=28, 43%). Results suggest that the app-based technology was well accepted and is a suitable supplement for AEFI reporting and in our study. A convincing data protection concept is likely to enhance acceptability of such a system.en_US
dc.language.isoenen_US
dc.publisherIngenta Connecten_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleUser preferences for a mobile application to report adverse events following vaccination.en_US
dc.typeArticleen_US
dc.contributor.departmentHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.en_US
dc.identifier.journalDie Pharmazieen_US
dc.source.volume75
dc.source.issue1
dc.source.beginpage27
dc.source.endpage31
refterms.dateFOA2021-03-19T14:46:18Z
dc.source.journaltitleDie Pharmazie
dc.source.countryGermany


Files in this item

Thumbnail
Name:
Nguyen et al.pdf
Size:
539.4Kb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International